Past webinars
Therapeutic Drug Monitoring of Busulfan and other Conditioning Chemotherapy: Optimizing Dosing for Individualized Therapy
The webinar was organised by the Pharmacist Committee on 20 November covered the importance of Therapeutic Drug Monitoring (TDM) for conditioning agents in hematopoietic stem cell transplantation, mainly focussing on busulfan. It provided an overview of TDM guidance and discussed best practices for implementing TDM services at individual centers.
Speaker panel:
Moderator:
- Mr Nick Duncan. Consultant Haematology Pharmacist. Queen Elizabeth Hospital, Birmingham, UK.
Speaker:
- Rick Admiraal, MD PhD, Clinical Research Fellow Pediatric Oncology and Clinical Pharmacologist, Princess Maxima Center for Pediatric Oncology, Netherlands.
- Claudia Langebrake, Priv.-Doz. Dr. Clinical Pharmacist. University Medical Center Hamburg-Eppendorf, Hospital Pharmacy and Department of Stem Cell Transplantation. Germany.
- Vera Domingos, PharmD. Hospital Pharmacist, Instituto Português de Oncologia de Lisboa Francisco Gentil, Portugal.
- Maria-Estela Moreno-Martinez, Clinical Pharmacist, BCOP. Hospital de la Santa Creu i Sant Pau, Barcelona. Spain.
- Karen Sweiss, PharmD. Clinical Assistant Professor. Clinical Pharmacist in Hematology and Stem Cell Transplant. University of Illinois at Chicago. UI Health. Chicago, USA.
Sponsorship
There are various opportunities to support the EBMT Educational Webinars. For more information, please send an email to fundraising@ebmt.org